Stoichiometry of the human glycine receptor revealed by direct subunit counting
Smith AC, Mears AJ, Bunker R, Ahmed A, MacKenzie M, Schwartzentruber JA, Beaulieu CL, Ferretti E, Majewski J, Bulman DE, Celik FC, Boycott KM, Graham GE (2014)
For ASM participants that receive a final score greater than zero as described at 512.745(a)(2)(i), calculate an ASM payment adjustment factor for each ASM participant within each ASM cohort by multiplying the ASM risk level, the ASM participant's transformed final score (calculated in Step 4), and the scaling factor (calculated in Step 5), and then subtracting the ASM risk level from this product as described at 512.750(c)(1)(i): ASM payment adjustment factor = (ASM risk level transformed final score scaling factor)ASM risk level Step 6B
If you wish to request information about reproducing figures or tables, please contact Bethany Hendrix, JCOPDF staff member at [email protected]
Over the years, weve dedicated more than 1,000 cumulative hours to researching therapeutic peptides
[DOI] [PubMed] [Google Scholar] 151.Jeong W, Yoon HW, Lee SR, Rhee SG
